SlidesetHIVInternational Workshop on HIV & Pediatrics 2015Efavirenz‐based therapy may simplify antiretroviral LPV‐based therapy initiated in HIV‐1‐infected children before the age of 2 in West‐Africa: the MONOD trial ANRS 12206 - Valeriane LeroyView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015Reasons for delayed ART initiation in children with HIV in South Africa - Chloe TeasdaleView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015Durability of first‐line antiretroviral therapy (ART) in children in the European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) - Ruth GoodallView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015The effect of systemic exposure to efavirenz, sex and age on the risk of virological non‐suppression in HIV‐infected African children - Andrzej BienczakView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015Lopinavir ritonavir (1:1 ratio) in the presence of rifampicin is not inferior to lopinavir ritonavir (4:1 ratio) in the absence of rifampicin in HIV children. Interim analysis of an open label sequential non- randomized phar- Mark CottonView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015Virologic Outcomes of Children Switched from Lopinavir/Ritonavir‐ to Efavirenz‐Based Antiretroviral Treatment: a retrospective cohort study - Kirsten ReichmuthView Slideset
EAElaine AbramsMDSlidesetHIVInternational Workshop on HIV & Pediatrics 2015Pediatric Treatment Cascade: What Do We Need to Reach “90‐90‐90” for Children - Elaine Abrams, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015CON ‐ standpoint - Diana Gibb, MD, MRCP, MScView Slideset
TRTed RuelMDSlidesetHIVInternational Workshop on HIV & Pediatrics 2015Debate: CD4 Assays Are No Longer Needed for Care of Children in Lowresource Countries - Ted Ruel, MDView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2015TDF Use Across the Age Spectrum: From Fetus to Adolescent - Anna Turkova, MDView Slideset
VideoINTEREST 2015Building laboratory networks and systems to prevent, detect and respond to antimicrobial resistance in Africa | Talkmore MarutaView Video
VideoINTEREST 2015Antimalarial Drug Resistance in South Africa: Past, Present and Future! | Jaishree RamanView Video
